Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
Human respiratory syncytial virus (HRSV) is the leading cause of bronchiolitis and pneumonia in infants, children, the elderly and the immune-compromised. The goal of immunization is to provide sufficient protection to prevent serious lower respiratory tract diseases leading to hospitalization and r...
Saved in:
Main Author: | Jalilian, Farid Azizi |
---|---|
Format: | Thesis |
Language: | English English |
Published: |
2011
|
Online Access: | http://psasir.upm.edu.my/id/eprint/19448/1/FBSB_2011_3_F.pdf http://psasir.upm.edu.my/id/eprint/19448/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of two Salmonella-based oral vaccines against human respiratory syncytial virus
by: Jalilian, F. Azizi, et al.
Published: (2015) -
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
by: Suhaimi, Siti Syazani
Published: (2011) -
Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
by: Jalilian, Farid Azizi, et al.
Published: (2011) -
A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
by: Lim, Erin Swee Hua
Published: (2010) -
Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach
by: ul Qamar, Muhammad Tahir, et al.
Published: (2020)